FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. (“Autoliv,” the “Company” or “we”) or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements.

In some cases, you can identify these statements by forward-looking words such as “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “may,” “likely,” “might,” “would,” “should,” “could,” or the negative of these terms and other comparable terminology, although not all forward-looking statements contain such words.

Because these forward-looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward-looking statements for a variety of reasons, including without limitation: general economic conditions, including inflation; changes in light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier; global supply chain disruptions, including port, transportation and distribution delays or interruptions; supply chain disruptions and component shortages specific to the automotive industry or the Company; disruptions and impacts relating to the ongoing war between Russia and Ukraine; changes in general industry and market conditions or regional growth or decline; changes in and the successful execution of our capacity alignments: restructuring, cost reduction and efficiency initiatives and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies, consolidations or restructuring or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing and other negotiations with customers; successful integration of acquisitions and operations of joint ventures; successful implementation of strategic partnerships and collaborations; our ability to be awarded new business; product liability, warranty and recall claims and investigations and other litigation, civil judgements or financial penalties and customer reactions thereto; higher expenses for our pension and other postretirement benefits, including higher funding needs for our pension plans; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims and the availability of insurance with respect to such matters; our ability to protect our intellectual property rights; negative impacts of antitrust investigations or other governmental investigations and associated litigation relating to the conduct of our business; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes impacting or limiting our business; our ability to meet our sustainability targets, goals and commitments; political conditions; dependence on and relationships with customers and suppliers; and other risks and uncertainties identified in Item 1A “Risk Factors” of this Quarterly Report on Form 10-Q, Item 1A “Risk Factors” and Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 16, 2023.

For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law.


INDEX	INDEX		INDEX

PART I - FINANCIAL INFORMATION	PART I - FINANCIAL INFORMATION	4	PART I - FINANCIAL INFORMATION	4

ITEM 1. FINANCIAL STATEMENTS	ITEM 1. FINANCIAL STATEMENTS	4	ITEM 1. FINANCIAL STATEMENTS	4

1.	Basis of Presentation	9	Basis of Presentation	10
2.	New Accounting Standards	10	New Accounting Standards	11
3.	Fair Value Measurements	11	Fair Value Measurements	12
4.	Income Taxes	14	Income Taxes	15
5.	Inventories	14	Inventories	15
6.	Restructuring	15	Restructuring	16
7.	Product-Related Liabilities	15	Product-Related Liabilities	16
8.	Retirement Plans	16	Retirement Plans	17
9.	Contingent Liabilities	17	Contingent Liabilities	18
10.	Stock Incentive Plan	19	Stock Incentive Plan	19
11.	Earnings Per Share	19	Earnings Per Share	20
12.	Revenue Disaggregation	20	Revenue Disaggregation	20
13.	Subsequent Events	20	Subsequent Events	20

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	21	ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	21
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	35	ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	34
ITEM 4. CONTROLS AND PROCEDURES	ITEM 4. CONTROLS AND PROCEDURES	35	ITEM 4. CONTROLS AND PROCEDURES	34
PART II - OTHER INFORMATION	PART II - OTHER INFORMATION	36	PART II - OTHER INFORMATION	35
ITEM 1. LEGAL PROCEEDINGS	ITEM 1. LEGAL PROCEEDINGS	36	ITEM 1. LEGAL PROCEEDINGS	35
ITEM 1A. RISK FACTORS	ITEM 1A. RISK FACTORS	36	ITEM 1A. RISK FACTORS	35
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	36	ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	35
ITEM 3. DEFAULTS UPON SENIOR SECURITIES	ITEM 3. DEFAULTS UPON SENIOR SECURITIES	36	ITEM 3. DEFAULTS UPON SENIOR SECURITIES	35
ITEM 4. MINE SAFETY DISCLOSURES	ITEM 4. MINE SAFETY DISCLOSURES	36	ITEM 4. MINE SAFETY DISCLOSURES	35
ITEM 5. OTHER INFORMATION	ITEM 5. OTHER INFORMATION	36	ITEM 5. OTHER INFORMATION	35
ITEM 6. EXHIBITS	ITEM 6. EXHIBITS	37	ITEM 6. EXHIBITS	36

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

(Dollars in millions, except per share data)


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022			2023			2022			2023			2022
Net sales	$	2,635		$	2,081		$	5,127		$	4,206		$	2,596		$	2,302		$	7,724		$	6,507
Cost of sales		(2,188	)		(1,755	)		(4,301	)		(3,591	)		(2,131	)		(1,918	)		(6,432	)		(5,510	)
Gross profit		447			326			826			614			465			383			1,291			998
Selling, general and administrative expenses		(129	)		(112	)		(261	)		(227	)		(118	)		(105	)		(379	)		(333	)
Research, development and engineering expenses, net		(120	)		(112	)		(237	)		(219	)		(107	)		(106	)		(343	)		(325	)
Amortization of intangibles		(0	)		(0	)		(1	)		(2	)		(1	)		(0	)		(1	)		(2	)
Other income (expense), net1)		(103	)		22			(107	)		92			(8	)		(1	)		(115	)		91
Operating income		94			124			221			258			232			171			453			429
Income from equity method investment		1			1			2			2			1			1			4			3
Interest income		6			1			8			2			3			2			10			4
Interest expense		(25	)		(13	)		(45	)		(26	)		(24	)		(15	)		(68	)		(41	)
Other non-operating items, net		7			5			5			1			(11	)		(6	)		(6	)		(5	)
Income before income taxes		83			117			191			237			201			153			393			389
Income tax expense		(30	)		(38	)		(64	)		(74	)		(67	)		(47	)		(131	)		(121	)
Net income2)		53			79			127			163			134			106			262			268
Less: Net income attributable to non-controlling interest		0			0			1			1			1			1			1			1
Net income attributable to controlling interest	$	53		$	79		$	127		$	162		$	134		$	105		$	261		$	267

Net earnings per share – basic	$	0.61		$	0.91		$	1.48		$	1.86		$	1.58		$	1.21		$	3.05		$	3.06
Net earnings per share – diluted	$	0.61		$	0.91		$	1.47		$	1.85		$	1.57		$	1.21		$	3.04		$	3.06

Weighted average number of shares outstanding, net of treasury shares (in millions)		85.6			87.2			85.9			87.2			84.9			87.0			85.5			87.2
Weighted average number of shares outstanding, assuming dilution and net of treasury shares (in millions)		85.8			87.3			86.0			87.4			85.0			87.2			85.7			87.4

Cash dividend per share – declared	$	0.66		$	0.64		$	1.32		$	1.28		$	0.66		$	0.64		$	1.98		$	1.92
Cash dividend per share – paid	$	0.66		$	0.64		$	1.32		$	1.28		$	0.66		$	0.64		$	1.98		$	1.92

1) The ~~three~~nine months period ending ~~June 30, 2022, includes a gain of $~~21 ~~million from a patent litigation settlement. The six months period ending June~~September 30, 2022, includes a gain on sale of property of $80 million in Japan ~~in the first quarter of 2022~~ and a gain of $21 million from a patent litigation ~~settlement in the second quarter of 2022.~~settlement.

2) For the three months ~~period~~periods ended ~~June~~September 30, 2023 and ~~June 30,~~ 2022, the aggregate transaction gain (loss) included in net income for the period were $(1016) million and $(911) million, respectively. For the ~~six~~nine months ~~period~~periods ended ~~June~~September 30, 2023 and ~~June 30,~~ 2022, the aggregate transaction gain (loss) included in net income for the period were $(1531) million and $(1526) million, respectively.

See Notes to the unaudited Condensed Consolidated Financial Statements.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

(Dollars in millions)


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022			2023			2022			2023			2022
Net income	$	53		$	79		$	127		$	163		$	134		$	106		$	262		$	268
Other comprehensive income before tax:
Other comprehensive income (loss) before tax:
Change in cumulative translation adjustments		(46	)		(121	)		(10	)		(115	)		(33	)		(98	)		(43	)		(214	)
Net change in unrealized components of defined benefit plans		5			3			5			15			1			(1	)		6			14
Other comprehensive income, before tax		(40	)		(118	)		(5	)		(100	)
Tax effect allocated to other comprehensive income		(1	)		(1	)		(1	)		(5	)
Other comprehensive income, net of tax		(41	)		(118	)		(6	)		(104	)
Other comprehensive (loss), before tax														(32	)		(99	)		(37	)		(200	)
Tax effect allocated to other comprehensive income (loss)														(0	)		0			(1	)		(4	)
Other comprehensive (loss), net of tax														(32	)		(99	)		(38	)		(203	)
Comprehensive income		12			(40	)		122			58			102			7			223			65
Less: Comprehensive income attributable to non-controlling interest		(0	)		(1	)		0			(0	)
Less: Comprehensive income (loss) attributable to non-controlling interest														0			0			0			(0	)
Comprehensive income attributable to controlling interest	$	12		$	(40	)	$	121		$	58		$	101		$	7		$	223		$	65

See Notes to the unaudited Condensed Consolidated Financial Statements.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Dollars in millions)


	As of						As of
	June 30, 2023			December 31, 2022			September 30, 2023			December 31, 2022
Assets
Cash and cash equivalents	$	475		$	594		$	475		$	594
Receivables, net		2,189			1,907			2,179			1,907
Inventories, net		947			969			982			969
Prepaid expenses and accrued income		166			160			180			160
Other current assets		120			84			63			84
Total current assets		3,898			3,714			3,879			3,714
Property, plant and equipment, net		2,047			1,960			2,067			1,960
Operating lease right-of-use assets		149			160			162			160
Goodwill		1,375			1,375			1,372			1,375
Intangible assets, net		6			7			6			7
Other non-current assets		484			502			500			502
Total assets		7,959			7,717			7,987			7,717

Liabilities and equity
Short-term debt		481			711			590			711
Accounts payable		1,844			1,693			1,858			1,693
Accrued expenses		1,122			915			1,093			915
Operating lease liabilities - current		35			39			37			39
Other current liabilities		274			283			274			283
Total current liabilities		3,756			3,642			3,851			3,642
Long-term debt		1,290			1,054			1,277			1,054
Pension liability		152			154			152			154
Operating lease liabilities - non-current		113			119			125			119
Other non-current liabilities		91			121			96			121
Total non-current liabilities		1,645			1,450			1,649			1,450
Common stock		90			91			89			91
Additional paid-in capital		1,096			1,113			1,072			1,113
Retained earnings		2,260			2,310			2,242			2,310
Accumulated other comprehensive loss		(527	)		(522	)		(560	)		(522	)
Treasury stock		(374	)		(379	)		(371	)		(379	)
Total controlling interest's equity		2,545			2,613			2,473			2,613
Non-controlling interest		13			13			13			13
Total equity		2,557			2,626			2,486			2,626
Total liabilities and equity	$	7,959		$	7,717		$	7,987		$	7,717

See Notes to the unaudited Condensed Consolidated Financial Statements.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Dollars in millions)


	Six Months Ended June 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Operating activities
Net income	$	127		$	163		$	262		$	268
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization		186			186			281			273
Gain on divestiture of property		—			(80	)		—			(80	)
Other, net		(8	)		7			1			(44	)
Net change in operating assets and liabilities		28			(257	)		(8	)		(168	)
Net cash provided by operating activities		334			19			535			251

Investing activities
Expenditures for property, plant and equipment		(268	)		(254	)		(420	)		(418	)
Proceeds from sale of property, plant and equipment		1			98			1			98
Net cash used in investing activities		(267	)		(156	)		(419	)		(319	)

Financing activities
Net increase (decrease) in short-term debt		5			(277	)		115			(110	)
Proceeds from long-term debt		556			269			557			251
Repayment of long-term debt		(533	)		(302	)		(533	)		(302	)
Dividends paid		(113	)		(112	)		(169	)		(167	)
Stock repurchased		(82	)		(40	)		(202	)		(60	)
Common stock options exercised		0			0			1			0
Dividend paid to non-controlling interest		(1	)		—			(1	)		(1	)
Net cash used in financing activities		(168	)		(462	)		(232	)		(389	)
Effect of exchange rate changes on cash and cash equivalents		(17	)		(43	)		(3	)		(28	)
Net decrease in cash and cash equivalents		(119	)		(642	)		(119	)		(486	)
Cash and cash equivalents at beginning of period		594			969			594			969
Cash and cash equivalents at end of period	$	475		$	327		$	475		$	483

See Notes to unaudited Condensed Consolidated Financial Statements.

CONSOLIDATED STATEMENTS OF TOTAL EQUITY (UNAUDITED) (Dollars in millions)


	Common stock			Additional paid-in capital			Retained earnings			Accumulated other comprehensive loss			Treasury stock			Total controlling interest's equity			Non- controlling interest			Total equity			Common stock			Additional paid-in capital			Retained earnings			Accumulated other comprehensive loss			Treasury stock			Total controlling interest's equity			Non- controlling interest			Total equity
Balances at December 31, 2022	$	91		$	1,113		$	2,310		$	(522	)	$	(379	)	$	2,613		$	13		$	2,626		$	91		$	1,113		$	2,310		$	(522	)	$	(379	)	$	2,613		$	13		$	2,626
Comprehensive Income:
Net income								74									74			0			74									74									74			0			74
Foreign currency translation adjustment											36						36			0			36												36						36			0			36
Pension liability											(0	)					(0	)					(0	)											(0	)					(0	)					(0	)
Total Comprehensive Income		—			—			74			35			—			110			0			110			—			—			74			35			—			110			0			110
Stock repurchased and retired		(0	)		(9	)		(33	)								(42	)					(42	)		(0	)		(9	)		(33	)								(42	)					(42	)
Stock-based compensation														3			3						3															3			3						3
Cash dividends declared								(57	)								(57	)					(57	)								(57	)								(57	)					(57	)
Balances at March 31, 2023	$	91		$	1,105		$	2,295		$	(487	)	$	(376	)	$	2,627		$	14		$	2,641		$	91		$	1,105		$	2,295		$	(487	)	$	(376	)	$	2,627		$	14		$	2,641
Comprehensive Income:
Net income								53									53			0			53									53									53			0			53
Foreign currency translation adjustment											(45	)					(45	)		(1	)		(46	)											(45	)					(45	)		(1	)		(46	)
Pension liability											4						4						4												4						4						4
Total Comprehensive Income		—			—			53			(41	)		—			12			(0	)		12			—			—			53			(41	)		—			12			(0	)		12
Stock repurchased and retired		(0	)		(9	)		(31	)								(41	)					(41	)		(0	)		(9	)		(31	)								(41	)					(41	)
Stock-based compensation														3			3						3															3			3						3
Dividends paid to non-controlling interest on subsidiary shares																																									0			(1	)		(1	)
Cash dividends declared								(56	)								(56	)					(56	)								(56	)								(56	)					(56	)
Balances at June 30, 2023																									$	90		$	1,096		$	2,260		$	(527	)	$	(374	)	$	2,545		$	13		$	2,557
Comprehensive Income:
Net income																																134									134			1			134
Foreign currency translation adjustment																																			(33	)					(33	)		(0	)		(33	)
Pension liability																																			1						1						1
Total Comprehensive Income																										—			—			134			(32	)		—			101			0			102
Stock repurchased and retired																										(1	)		(23	)		(95	)								(120	)					(120	)
Stock-based compensation																																						3			3						3
Dividends paid to non-controlling interest on subsidiary shares																	0			(1	)		(1	)																				—			—
Balances at June 30, 2023	$	90		$	1,096		$	2,260		$	(527	)	$	(374	)	$	2,545		$	13		$	2,557
Cash dividends declared																																(56	)								(56	)					(56	)
Balances at September 30, 2023																									$	89		$	1,072		$	2,242		$	(560	)	$	(371	)	$	2,473		$	13		$	2,486

Common
stock

Additional
paid-in
capital

Retained
earnings

Accumulated
other
comprehensive
loss

Treasury
stock

Total
controlling
interest's
equity

Non-
controlling
interest

Total
equity

Balances at December 31, 2021
$
103

$
1,329

$
2,742

$
(408
)

$
(1,133
)

$
2,633

$
15

$
2,648

Comprehensive Loss:

Net income

83

83

0

83

Foreign currency translation
  adjustment

6

6

0

6

Pension liability

8

8

8

Total Comprehensive Income

—

—

83

14

—

97

0

98

Retired and repurchased shared

(0
)

(4
)

(13
)

(18
)

(18
)
Stock-based compensation

2

2

2

Cash dividends declared

(56
)

(56
)

(56
)
Balances at March 31, 2022
$
103

$
1,325

$
2,755

$
(393
)

$
(1,131
)

$
2,659

$
15

$
2,674

Comprehensive Loss:

       Net income

79

79

0

79

       Foreign currency translation
         adjustment

(121
)

(121
)

(1
)

(122
)
      Pension liability

3

3

3

Total Comprehensive Loss

—

—

79

(119
)

—

(40
)

(1
)

(40
)
Retired and repurchased shared

(0
)

(6
)

(16
)

(22
)

(22
)
Stock-based compensation

2

2

2

Cash dividends declared

(56
)

(56
)

(56
)
Balances at June 30, 2022
$
102

$
1,319

$
2,762

$
(512
)

$
(1,128
)

$
2,544

$
15

$
2,558


	Common stock			Additional paid-in capital			Retained earnings			Accumulated other comprehensive loss			Treasury stock			Total controlling interest's equity			Non- controlling interest			Total equity
Balances at December 31, 2021	$	103		$	1,329		$	2,742		$	(408	)	$	(1,133	)	$	2,633		$	15		$	2,648
Comprehensive Loss:
Net income								83									83			0			83
Foreign currency translation adjustment											6						6			0			6
Pension liability											8						8						8
Total Comprehensive Income		—			—			83			14			—			97			0			98
Retired and repurchased shared		(0	)		(4	)		(13	)								(18	)					(18	)
Stock-based compensation														2			2						2
Cash dividends declared								(56	)								(56	)					(56	)
Balances at March 31, 2022	$	103		$	1,325		$	2,755		$	(393	)	$	(1,131	)	$	2,659		$	15		$	2,674
Comprehensive Loss:
Net income								79									79			0			79
Foreign currency translation adjustment											(121	)					(121	)		(1	)		(122	)
Pension liability											3						3						3
Total Comprehensive Loss		—			—			79			(119	)		—			(40	)		(1	)		(40	)
Retired and repurchased shared		(0	)		(6	)		(16	)								(22	)					(22	)
Stock-based compensation														2			2						2
Cash dividends declared								(56	)								(56	)					(56	)
Balances at June 30, 2022	$	102		$	1,319		$	2,762		$	(512	)	$	(1,128	)	$	2,544		$	15		$	2,558
Comprehensive Income:
Net income								105									105			1			106
Foreign currency translation adjustment											(98	)					(98	)		(1	)		(99	)
Pension liability											(1	)					(1	)					(1	)
Total Comprehensive Income (loss)		—			—			105			(98	)		—			7			0			7
Retired and repurchased shared		(0	)		(4	)		(15	)								(20	)					(20	)
Stock-based compensation														3			3						3
Dividends paid to non-controlling interest on subsidiary shares																				(1	)		(1	)
Cash dividends declared								(56	)								(56	)					(56	)
Balances at September 30, 2022	$	102		$	1,315		$	2,797		$	(610	)	$	(1,125	)	$	2,478		$	13		$	2,491

See Notes to the unaudited Condensed Consolidated Financial Statements.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unless otherwise noted, all amounts are presented in millions of dollars, except for per share amounts)

~~June~~September 30, 2023

1. BASIS OF PRESENTATION

The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the prior year audited consolidated financial statements and all adjustments considered necessary for a fair presentation have been included in the consolidated financial statements. All such adjustments are of a normal recurring nature. The results for the interim period are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending December 31, 2023.

The Condensed Consolidated Balance Sheet as of December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements.

The Company has one reportable segment, which includes Autoliv’s airbag and seatbelt products and components.

Certain amounts in the condensed consolidated financial statements and associated notes may not reconcile due to rounding. All percentages have been calculated using unrounded amounts. Certain amounts in prior periods have been reclassified to conform to current year presentation.

Statements in this report that are not of historical fact are forward-looking statements that involve risks and uncertainties that could affect the actual results of the Company. A description of the important factors that could cause Autoliv’s actual results to differ materially from the forward-looking statements contained in this report may be found in this report and Autoliv’s other reports filed with the Securities and Exchange Commission (the “SEC”). For further information, refer to the consolidated financial statements, footnotes and definitions thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 16, 2023.

910

2. NEW ACCOUNTING STANDARDS

Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification (“ASC”).

Adoption of new accounting standards

In September 2022, the FASB issued ASU 2022-04, Liabilities-Supplier Finance Programs (Subtopic 405-50), Disclosure of Supplier Finance Program Obligations, which requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period and potential magnitude. During the fiscal year of adoption, the information on the key terms of the programs and the balance sheet presentation of the program obligations, which are annual disclosure requirements, should be disclosed in each interim period. The amendments in this update should be applied retrospectively to each period in which a balance sheet is presented, except for the amendment on roll-forward information, which should be applied prospectively.

The Company adopted ASU 2022-04 as of January 1, 2023. The Company has an agreement with an external payment service provider to facilitate the payments to certain suppliers. The outstanding obligations confirmed towards the external payment service provider are recorded in Accounts Payable in the Condensed Consolidated Balance Sheet until payment has been effected. The Company has undertaken to make sure the payment is effected on the original invoice maturity date. The payment terms range between 30 days and 165 days, with a weighted average of ~~130~~127 days.

The roll-forward of the Company's outstanding obligations confirmed as valid under its supplier finance program for the ~~six~~nine months period ended ~~June~~September 30, 2023 is as follows (dollars in millions):


	As of			Nine Months Ended
	June 30, 2023			September 30, 2023
Confirmed obligations outstanding at beginning of the period	$	314		$	314
Invoices confirmed during the period		680			1,046
Confirmed invoices paid during the period		(661	)		(1,030	)
Confirmed obligations outstanding at end of the period1)	$	333		$	330

1) Amount of obligations confirmed under the program that remains unpaid by the Company is reported as Accounts Payable in the Condensed Consolidated Balance Sheet.

Accounting standards issued but not yet adopted

None.

1011

3. FAIR VALUE MEASUREMENTS

Assets and liabilities measured at fair value on a recurring basis

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and other current financial assets and liabilities approximate their fair value because of the short-term maturity of these instruments.

The Company uses derivative financial instruments (“derivatives”) as part of its debt management to mitigate the market risk that occurs from its exposure to changes in interest rates and foreign exchange rates. The Company does not enter into derivatives for trading or other speculative purposes. The Company’s use of derivatives is in accordance with the strategies contained in the Company’s overall financial policy. All derivatives are recognized in the consolidated financial statements at fair value. For certain derivatives, hedge accounting is not applied either because non-hedge accounting treatment creates the same accounting result or the hedge does not meet the hedge accounting requirements, although each hedge is entered into applying the same rationale concerning mitigating market risk that occurs from changes in interest rates and foreign exchange rates.

The degree of judgment utilized in measuring the fair value of the instruments generally correlates to the level of pricing observability. Pricing observability is impacted by several factors, including the type of asset or liability, whether the asset or liability has an established market and the characteristics specific to the transaction. Instruments with readily active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of pricing observability and a lesser degree of judgment utilized in measuring fair value. Conversely, assets rarely traded or not quoted will generally have less, or no, pricing observability and a higher degree of judgment utilized in measuring fair value.

All the Company’s derivatives are classified as Level 2 financial instruments in the fair value hierarchy. Level 2 pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reported date. The nature of these assets and liabilities include items for which quoted prices are available but traded less frequently, and items that are fair valued using other financial instruments, the parameters of which can be directly observed.

The carrying value is the same as the fair value as these instruments are recognized in the consolidated financial statements at fair value. Although the Company is party to close-out netting agreements (“ISDA agreements”) with all derivative counterparties, the fair values in the tables below and in the Condensed Consolidated Balance Sheets as of ~~June~~September 30, 2023 and December 31, 2022 have been presented on a gross basis. According to the ISDA agreements, transaction amounts payable to a counterparty on the same date and in the same currency can be netted. The amounts subject to netting agreements that the Company chose not to offset are presented below.

Derivatives designated as hedging instruments

There were no derivatives designated as hedging instruments as of ~~June~~September 30, 2023 or December 31, 2022 related to the Company's operations.

1112

Derivatives not designated as hedging instruments

Derivatives not designated as hedging instruments relate to economic hedges and are marked to market with all amounts recognized in the Consolidated Statements of Income. The derivatives not designated as hedging instruments outstanding as of ~~June~~September 30, 2023 and December 31, 2022 were foreign exchange swaps.

For the three months ~~period~~periods ended ~~June 30, 2023 and June 30, 2022, the gains (losses) recognized in other non-operating items, net were $~~13 ~~million and $(~~23~~) million, respectively, for derivative instruments not designated as hedging instruments. For the six months period ended June~~September 30, 2023 and 2022, the gains (losses) recognized in other non-operating items, net were $812 million and $(149) million, respectively, for derivative instruments not designated as hedging instruments. For the nine months periods ended September 30, 2023 and 2022, the gains (losses) recognized in other non-operating items, net were $21 million and $(24) million, respectively. The realized part of the losses referred to above is reported under financing activities in the statement of cash flows.

For the three and ~~six~~nine months periods ended ~~June~~September 30, 2023 and ~~June~~September 30, 2022, the gains (losses) recognized as interest expense were immaterial.

The tables below present information about the Company’s derivative financial assets and liabilities measured at fair value on a recurring basis (dollars in millions).


	As of																		As of
	June 30, 2023									December 31, 2022									September 30, 2023									December 31, 2022
				Fair Value Measurements									Fair Value Measurements									Fair Value Measurements									Fair Value Measurements
Description	Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)			Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)			Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)			Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)
Derivatives not designated as hedging instruments
Foreign exchange swaps, less than 6 months	$	1,710	1)	$	10	2)	$	8	3)	$	2,616	4)	$	22	5)	$	15	6)	$	2,016	1)	$	13	2)	$	25	3)	$	2,616	4)	$	22	5)	$	15	6)
Total derivatives not designated as hedging instruments	$	1,710		$	10		$	8		$	2,616		$	22		$	15		$	2,016		$	13		$	25		$	2,616		$	22		$	15

1) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $~~1,710~~2,016 million.

2) Net amount after deducting for offsetting swaps under ISDA agreements is $1013 million.

3) Net amount after deducting for offsetting swaps under ISDA agreements is $825 million.

4) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $2,616 million.

5) Net amount after deducting for offsetting swaps under ISDA agreements is $22 million.

6) Net amount after deducting for offsetting swaps under ISDA agreements is $15 million.

1213

Fair Value of Debt

The fair value of long-term debt is determined either from quoted market prices as provided by participants in the secondary market or for long-term debt without quoted market prices, estimated using a discounted cash flow method based on the Company’s current borrowing rates for similar types of financing. The Company has determined that each of these fair value measurements of debt reside within Level 2 of the fair value hierarchy.

During the first quarter of 2023, the Company issued a five-year €500 million Eurobond. These notes were issued as green bonds. In the second quarter of 2023, the Company repaid the €500 million for the five-year Eurobond that matured in June 2023.

The fair value and carrying value of debt is summarized in the table below (dollars in millions).


	As of								As of
	June 30, 2023				December 31, 2022				September 30, 2023				December 31, 2022
	Carrying value1)		Fair value		Carrying value1)		Fair value		Carrying value1)		Fair value		Carrying value1)		Fair value
Long-term debt
Bonds	$	1,013	$	984	$	767	$	735	$	1,000	$	980	$	767	$	735
Loans		276		283		287		292		277		282		287		292
Other long-term debt		1		1		—		—
Total long-term debt		1,290		1,268		1,054		1,027		1,277		1,262		1,054		1,027

Short-term debt
Short-term portion of long-term debt		297		289		533		527		297		295		533		527
Overdrafts and other short-term debt		184		184		178		178		293		293		178		178
Total short-term debt	$	481	$	473	$	711	$	705	$	590	$	588	$	711	$	705

1) Debt as reported in balance sheet.

Assets and liabilities measured at fair value on a nonrecurring basis

In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company also has assets and liabilities in its balance sheet that are measured at fair value on a nonrecurring basis, including certain long-lived assets, including equity method investments, goodwill and other intangible assets, typically as it relates to impairment.

The Company has determined that the fair value measurements included in each of these assets and liabilities rely primarily on Company-specific inputs and the Company’s assumptions about the use of the assets and settlements of liabilities, as observable inputs are not available. The Company has determined that each of these fair value measurements reside within Level 3 of the fair value hierarchy. To determine the fair value of long-lived assets, the Company utilizes the projected cash flows expected to be generated by the long-lived assets, then discounts the future cash flows over the expected life of the long-lived assets.

For the three and ~~six~~nine months periods ended ~~June~~September 30, 2023 and ~~June~~September 30, 2022, the Company did not record any material impairment charges on its long-lived assets for its operations.

1314

4. INCOME TAXES

The effective tax rate for the three months period ended ~~June~~September 30, 2023 was ~~35.8~~33.4% compared to ~~32.2~~30.8% for the three months period ended ~~June~~September 30, 2022. Discrete tax items, net for the three months period ended ~~June~~September 30, 2023 had ~~a favorable~~an unfavorable impact of ~~4.5~~0.2%. Discrete tax items, net for the three months period ended ~~June~~September 30, 2022 had an unfavorable impact of ~~1.5~~1.4%.

The effective tax rate for the ~~six~~nine months period ended ~~June~~September 30, 2023 was 33.4% compared to ~~31.3~~31.1% for the ~~six~~nine months period ended ~~June~~September 30, 2022. Discrete tax items, net for the ~~six~~nine months period ended ~~June~~September 30, 2023 had a favorable impact of ~~1.5~~0.6%. Discrete tax items, net for the ~~six~~nine months period ended ~~June~~September 30, 2022 had an unfavorable impact of ~~1.0~~1.2%.

The Company files income tax returns in the U.S. federal jurisdiction, various U.S. states and non-U.S. jurisdictions. At any given time, the Company is undergoing tax audits in several tax jurisdictions covering multiple years. The Company is no longer subject to income tax examination by the U.S. federal income tax authorities for years prior to 2015. With few exceptions, the Company is no longer subject to income tax examination by U.S. state or local tax authorities or by non-U.S. tax authorities for years before 2012.

As of ~~June~~September 30, 2023, the Company is not aware of any proposed income tax adjustments resulting from tax examinations that would have a material impact on the Company’s condensed consolidated financial statements. The conclusion of such audits could result in additional increases or decreases to unrecognized tax benefits in some future period or periods.

During the ~~six~~nine months period ended ~~June~~September 30, 2023, the Company recorded a net increase of $67 million to income tax reserves for unrecognized tax benefits based on tax positions related to the current year, including accruing additional interest related to unrecognized tax benefits from prior years. Of the total unrecognized tax benefits of $5253 million recorded as of ~~June~~September 30, 2023, $1516 million is classified as current tax payable within Other current liabilities and $37 million is classified as non-current tax payable within Other non-current liabilities on the Condensed Consolidated Balance Sheet.

5. INVENTORIES

Inventories are stated at the lower of cost (“FIFO”) and net realizable value. The components of inventories were as follows (dollars in millions):


	As of						As of
	June 30, 2023			December 31, 2022			September 30, 2023			December 31, 2022
Raw materials	$	436		$	445		$	454		$	445
Work in progress		333			350			325			350
Finished products		267			265			289			265
Inventories		1,035			1,060			1,068			1,060
Inventory valuation reserve		(89	)		(91	)		(87	)		(91	)
Total inventories, net of reserve	$	947		$	969		$	982		$	969

1415

6. RESTRUCTURING

As of ~~June~~September 30, 2023, approximately $105 million ~~out~~ of the $~~127~~122 million in total reserve balance can be attributed to footprint optimization activities in Europe, mainly Germany and the United Kingdom (UK)~~, initiated in the second quarter of 2023.~~ amounting to $89 million. These activities are expected to be concluded during 2024 and 2025.

The provision ~~charge~~charges for the three and ~~six~~nine months periods ended ~~June~~September 30, 2023 mainly relate to restructuring activities in Germany and ~~the~~ UK. The cash payments for the three and nine months ~~period~~periods ended ~~June~~September 30, ~~2022 related~~2023 relate to restructuring activities in ~~Europe and Asia.~~Europe. The majority of the cash payments for the ~~six~~nine months period ended ~~June~~September 30, 2022 mainly related to footprint optimization activities in Asia.

The table below summarizes the change in the balance sheet position of the employee-related restructuring reserves (dollars in millions). The restructuring reserve balances are included within Accrued expenses in the Condensed Consolidated Balance Sheets. The changes in the employee-related reserves have been charged against Other income (expense), net in the Consolidated Statements of Income. Restructuring costs other than employee related costs are immaterial for all periods presented.


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022			2023			2022			2023			2022
Reserve at beginning of the period	$	29		$	58		$	32		$	88		$	127		$	45		$	32		$	88
Provision - charge		107			0			110			12			8			2			118			14
Provision - reversal		(0	)		(0	)		(0	)		(0	)		(1	)		(1	)		(1	)		(1	)
Cash payments		(9	)		(9	)		(15	)		(50	)		(9	)		(9	)		(24	)		(59	)
Translation difference		(0	)		(4	)		0			(5	)		(3	)		(3	)		(2	)		(8	)
Reserve at end of the period	$	127		$	45		$	127		$	45		$	122		$	34		$	122		$	34

7. PRODUCT-RELATED LIABILITIES

The Company is exposed to product liability and warranty claims in the event that the Company’s products fail to perform as represented and such failure results, or is alleged to result, in bodily injury, and/or property damage or other loss. The Company has reserves for product risks. Such reserves are related to product performance issues, including recalls, product liability and warranty issues. For further explanation, see Note 9. Contingent Liabilities below.

For the three and ~~six~~nine months periods ended ~~June~~September 30, 2023, provisions ~~and cash payments~~ primarily relate to warranty related ~~issues.~~issues and cash payments mainly relate to the Andrews litigation settlement. For the three and ~~six~~nine months periods ended ~~June~~September 30, 2022, provisions and cash payments primarily related to warranty related issues. As of ~~June~~September 30, 2023, the reserve for product related liabilities mainly relate to recall related issues.

The table below summarizes the change in the balance sheet position of the product-related liabilities (dollars in millions). The reserve for product related liabilities is included in accrued expenses and ~~Other~~other non-current liabilities on the Condensed Consolidated Balance Sheets. A majority of the Company’s product-related liabilities as of ~~June~~September 30, 2023 are covered by insurance. Insurance receivables are included within ~~Other~~other current assets and ~~Other~~other non-current assets on the Condensed Consolidated Balance Sheets. As of ~~June~~September 30, 2023, the Company had total insurance receivables of $~~169~~120 million.


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022			2023			2022			2023			2022
Reserve at beginning of the period	$	141		$	150		$	145		$	144		$	178		$	145		$	145		$	144
Change in reserve		42			2			43			12			3			5			46			17
Cash payments		(4	)		(5	)		(9	)		(8	)		(61	)		(3	)		(71	)		(12	)
Translation difference		(0	)		(2	)		(0	)		(2	)		(0	)		(2	)		(1	)		(3	)
Reserve at end of the period	$	178		$	145		$	178		$	145		$	120		$	146		$	120		$	146

1516

8. RETIREMENT PLANS

The components of total Net Periodic Benefit Cost associated with the Company’s defined benefit retirement plans are as follows (dollars in millions):


U.S. Plans	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022			2023			2022			2023			2022
Interest cost	$	3		$	4			6			6		$	3		$	3		$	9		$	9
Expected return on plan assets		(3	)		0			(5	)		(4	)		(3	)		(7	)		(8	)		(11	)
Settlement loss		0			0			0			1			1			2			1			3
Net periodic benefit cost	$	0		$	4		$	1		$	3		$	1		$	(2	)	$	2		$	1
Non-U.S. Plans	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022			2023			2022			2023			2022
Service cost	$	3		$	2		$	5		$	5		$	2		$	2		$	7		$	7
Interest cost		3			2			5			3			2			1			7			4
Expected return on plan assets		0			(1	)		(1	)		(1	)		(1	)		(0	)		(2	)		(1	)
Amortization of actuarial loss														1			1			1			1
Settlement/curtailment gain		0			(4	)		0			(5	)		0			(0	)		0			(5	)
Net periodic benefit cost (gain)	$	6		$	(1	)	$	9		$	2		$	4		$	4		$	13		$	6

The Service cost component in the table above is reported among other employee compensation costs in the Consolidated Statements of Income. The remaining components - Interest cost, Expected return on plan assets, Amortization of actuarial loss, Settlement loss (gain) and Curtailment gain - are reported as Other non-operating items, net in the Consolidated Statements of Income.

~~Settlement~~The Company triggered settlement accounting ~~has been triggered~~ for the primary U.S. pension plan in the ~~second~~third quarter of 2023 because the lump-sum payments made during the quarter exceeded the sum of Service cost and Interest cost for this U.S. plan. Due to the settlement accounting, the obligation and plan assets for the primary U.S. plan have been re-measured as of ~~June~~September 30, 2023, which resulted in an immaterial change in the net pension liability compared to December 31, 2022. The discount rate used to determine the U.S. net periodic benefit cost because of the re-measurement was changed from ~~5.09~~5.32% to ~~5.32~~5.98% in the ~~second~~third quarter of 2023. The expected long-term rate of return on plan asset is unchanged at 5.05%.

1617

9. CONTINGENT LIABILITIES

Legal Proceedings

Various claims, lawsuits and proceedings are pending or threatened against the Company or its subsidiaries, covering a range of matters that arise in the ordinary course of its business activities with respect to commercial, product liability and other matters. Litigation is subject to many uncertainties, and the outcome of any litigation cannot be assured. After discussions with counsel, and with the exception of losses resulting from the antitrust proceedings described below, it is the opinion of management that the various legal proceedings and investigations to which the Company currently is a party will not have a material adverse impact on the consolidated financial position of Autoliv, but the Company cannot provide assurance that Autoliv will not experience material litigation, product liability or other losses in the future.

ANTITRUST MATTERS

Authorities in several jurisdictions have conducted broad, and in some cases, long-running investigations of suspected anti-competitive behavior among parts suppliers in the global automotive vehicle industry. These investigations included, but are not limited to, the products that the Company sells. In addition to concluded matters, authorities of other countries with significant light vehicle manufacturing or sales may initiate similar investigations.

PRODUCT WARRANTY, RECALLS AND INTELLECTUAL PROPERTY

Autoliv is exposed to various claims for damages and compensation if its products fail to perform as expected. Such claims can be made, and result in costs and other losses to the Company, even where the product is eventually found to have functioned properly. Where a product (actually or allegedly) fails to perform as expected or is defective, the Company may face warranty and recall claims. Where such (actual or alleged) failure or defect results, or is alleged to result, in bodily injury and/or property damage, the Company may also face product liability and other claims. There can be no assurance that the Company will not experience material warranty, recall or product (or other) liability claims or losses in the future, or that the Company will not incur significant costs to defend against such claims. The Company may be required to participate in a recall involving its products. Each vehicle manufacturer has its own practices regarding product recalls and other product liability actions relating to its suppliers. As suppliers become more integrally involved in the vehicle design process and assume more of the vehicle assembly functions, vehicle manufacturers are increasingly looking to their suppliers for contribution when faced with recalls and product liability claims. Government safety regulators may also play a role in warranty and recall practices. Recall decisions regarding the Company’s products may require a significant amount of judgment by us, our customers and safety regulators and are influenced by a variety of factors. Once a recall has been made, the cost of a recall is also subject to a significant amount of judgment and discussions between the Company and its customers. A warranty, recall or product-liability claim brought against the Company in excess of its insurance may have a material adverse effect on the Company’s business. Vehicle manufacturers are also increasingly requiring their outside suppliers to guarantee or warrant their products and bear the costs of repair and replacement of such products under new vehicle warranties. A vehicle manufacturer may attempt to hold the Company responsible for some, or all, of the repair or replacement costs of products when the product supplied did not perform as represented by us or expected by the customer in either a warranty or a recall situation. Accordingly, the future costs of warranty or recall claims by the customers may be material. However, the Company believes its established reserves are adequate. Autoliv’s warranty reserves are based upon the Company’s best estimates of amounts necessary to settle future and existing claims. The Company regularly evaluates the adequacy of these reserves and adjusts them when appropriate. However, the final amounts actually due related to these matters could differ materially from the Company’s recorded estimates.

In addition, as vehicle manufacturers increasingly use global platforms and procedures, quality performance evaluations are also conducted on a global basis. Any one or more quality, warranty or other recall issue(s) (including those affecting few units and/or having a small financial impact) may cause a vehicle manufacturer to implement measures such as a temporary or prolonged suspension of new orders, which may have a material impact on the Company’s results of operations.

The Company maintains a program of insurance, which may include commercial insurance, self-insurance, or a combination of both approaches, for potential recall and product liability claims in amounts and on terms that it believes are reasonable and prudent based on our prior claims experience. The Company’s insurance policies generally include coverage of the costs of a recall, although costs related to replacement parts are generally not covered. In addition, a number of the agreements entered into by the Company, including the Spin-off Agreements, require Autoliv to indemnify the other parties for certain claims. Autoliv cannot assure that the level of coverage will be sufficient to cover every possible claim that can arise in our businesses or with respect to other obligations, now or in the future, or that such coverage always will be available should we, now or in the future, wish to extend, increase or otherwise adjust our insurance.

1718

Product Liability:

On ~~September 18, 2014~~, ~~Jamie Andrews~~ filed a wrongful death products liability suit against several Autoliv entities stemming from a fatal car accident in 2013 where the plaintiff’s husband was fatally injured. The lawsuit alleges that Autoliv should be liable for a defectively-designed driver seatbelt. The case was removed to the United States District Court for the Northern District of Georgia. The suit originally included Bosch and Mazda entities as well, but these entities were dismissed pursuant to confidential settlement agreements with the plaintiff, and all of the Autoliv entities except Autoliv Japan Ltd. were also dismissed. On January 10, 2017, the District Court entered an order granting summary judgment in favor of Autoliv, concluding that Autoliv was not actively involved in the design of Mr. Andrews’s seatbelt and, therefore, should not be liable for plaintiff’s claims as a matter of law. However, on appeal, the Eleventh Circuit Court of Appeals reversed the decision, holding that, under Georgia’s products liability statute, Autoliv could be liable for a design defect associated with the seatbelt, regardless of its level of involvement in the seatbelt’s ultimate design, because Autoliv manufactured it. On October 4, 2021, the case proceeded to a bench trial before the United States District Court for the Northern District of Georgia. On December 31, 2021, the District Court entered a Final Order and Judgment concluding that Mr. Andrews’s seatbelt was defectively designed and Autoliv was strictly liable for the design. ~~In doing so, the District Court concluded that Mr. Andrews had incurred $27,019,343~~ ~~in compensatory damages, but only ordered Autoliv to pay 50 percent of that amount, $13,509,671~~ ~~after finding that 50 percent of the fault for Mr. Andrews’s damages should be apportioned to Mazda. The Court declined to apportion any fault for Mr. Andrews’s damages to Mr. Andrews or Bosch. The District Court also entered an award of punitive damages against Autoliv in the amount of $100,000,000. Subsequently, on September 30, 2022, the District Court awarded pre-judgment interest on the compensatory damages award of approximately $4,734,350~~. The Company believes the District Court's verdict was in error, including the grossly high punitive damages award, and appealed the verdict. Ms. Andrews also initiated a cross-appeal. The Company determined that a loss with respect to this litigation is probable and in the fourth quarter of 2021 accrued $14 ~~million pursuant to ASC 450. The Company accrued an additional $~~5 million for the pre-judgement interest in the third quarter of 2022. On July 18, 2023, the Company, without admitting any liability, executed settlement agreements and resolved the lawsuit with all interested parties. The final amount by which the product liability accrual exceeds the product liability insurance receivable is $8 ~~million and includes self-insurance retention costs and deductibles.~~

In June 2023, several Autoliv subsidiaries were named as defendants in a class action lawsuit filed in the United States District Court for the Eastern District of Michigan by David Anderson, et al. These subsidiaries were also named defendants in a class action filed in the Western District of Tennessee in September ~~2022 but have not yet been served.~~2022. The plaintiffs in these lawsuits (the "ARC Inflator Class Action") generally allege that the defendants have violated various state competition, warranty, and trade practice laws relating to ARC inflators included in airbag modules that the defendants allegedly supplied after Autoliv acquired certain Delphi assets (the "Delphi Acquisition") in December 2009. The Company denies these allegations. Autoliv is not aware of any performance issues regarding ARC inflators included with its airbags at the directions of its customers that it shipped following the Delphi Acquisition. The Company has determined pursuant to ASC 450 that a loss is reasonably possible with respect to the ARC Inflator Class Action. However, the Company continues to evaluate this matter, no accrual has been made, and no estimated range of potential loss can be determined at this time. The Company cannot predict the ultimate outcome of the ARC Inflator Class Action.

Specific Recalls:

In the fourth quarter of 2020, the Company was made aware of a potential recall by American Honda Motor Co. and the recall of approximately 449,000 vehicles relating to the malfunction of front seat belt buckles was announced on March 9, 2023 (the “Honda Buckle Recall”). The Company determined pursuant to ASC 450 that a loss with respect to the Honda Buckle Recall is probable and accrued an amount that is reflected in the total product liability accrual in the fourth quarter of 2020 and increased the accrual in the fourth quarter of 2021. The amount by which the product liability accrual exceeds the product liability insurance receivable with respect to the Honda Buckle Recall is $27 million and includes self-insurance retention costs and deductibles. The ultimate loss to the Company of the Honda Buckle Recall could be materially different from the amount the Company has accrued.

Volvo Car USA, LLC (together with its affiliates, “Volvo”) has recalled approximately 762,000 vehicles relating to the malfunction of inflators produced by ZF (the “ZF Inflator Recall”). The recalled ZF inflators were included in airbag modules supplied by the Company only to Volvo. The recall commenced in November 2020 and later expanded in September 2021. Because the Company’s airbags were involved with the ZF Inflator Recall, the Company has determined pursuant to ASC 450 that a loss is reasonably possible with respect to the ZF Inflator Recall. The Company continues to evaluate this matter with Volvo and ZF and no accrual has been made. Although the Company currently estimates a range of $0 to $43 million with respect to this potential loss, the Company anticipates that any losses net of insurance claims and claims against ZF will be immaterial.

Intellectual Property:

In its products, the Company utilizes technologies which may be subject to intellectual property rights of third parties. While the Company does seek to procure the necessary rights to utilize intellectual property rights associated with its products, it may fail to do so. Where the Company so fails, the Company may be exposed to material claims from the owners of such rights. Where the Company has sold products which infringe upon such rights, its customers may be entitled to be indemnified by the Company for the claims they suffer as a result thereof. Such claims could be material.

The table in Note 7 above summarizes the change in the balance sheet position of the product-related liabilities.

10. STOCK INCENTIVE PLAN

Eligible employees and non-employee directors of the Company participate in the Autoliv, Inc.1997 Stock Incentive Plan, as amended, (“the Plan”), and receive Autoliv stock-based awards which include restricted stock units (“RSUs”) and performance stock units (“PSUs”) and in the past included stock options.

For the three and ~~six~~nine months periods ended ~~June~~September 30, 2023, the Company recorded approximately $53 million and $8 million, respectively, in stock-based compensation expense related to RSUs and PSUs. For the three and ~~six~~nine months periods ended ~~June~~September 30, 2022, the Company recorded approximately $3 million and $57 million, respectively, in stock-based compensation expense related to RSUs and PSUs.

During the three and ~~six~~nine months periods ended ~~June~~September 30, 2023, approximately 208 thousand and ~~112~~120 thousand shares of common stock from the treasury stock were utilized by the Plan. During the three and ~~six~~nine months periods ended ~~June~~September 30, 2022, approximately 165 thousand and ~~138~~144 thousand shares, respectively, of common stock from the treasury stock were utilized by the Plan.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our Condensed Consolidated Financial Statements and accompanying Notes thereto included elsewhere herein and with our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the United States Securities and Exchange Commission (the “SEC”) on February 16, 2023. Unless otherwise noted, all dollar amounts are in millions.

Autoliv, Inc. (“Autoliv” or the “Company”) is a Delaware corporation with its principal executive offices in Stockholm, Sweden. The Company functions as a holding corporation and owns two principal operating subsidiaries, Autoliv AB and Autoliv ASP, Inc.

Through its operating subsidiaries, Autoliv is a supplier of automotive safety systems with a broad range of product offerings, including modules and components for passenger and driver airbags, side airbags, curtain airbags, seatbelts, steering wheels and pedestrian protection systems.

Autoliv’s filings with the SEC, including this Quarterly Report on Form 10-Q, annual reports on Form 10-K, current reports on Form 8-K, proxy statements and all of our other reports and statements, and amendments thereto, are available free of charge on our corporate website at www.autoliv.com as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC (generally the same day as the filing).

The primary exchange market for Autoliv’s securities is the New York Stock Exchange ("NYSE") where Autoliv’s common stock trades under the symbol “ALV”. Autoliv’s Swedish Depositary Receipts ("SDRs") are traded on Nasdaq Stockholm’s list for large market cap companies under the symbol “ALIV SDB”. Options in SDRs trade on Nasdaq Stockholm under the name “Autoliv SDB”. Options in Autoliv shares are traded on Nasdaq OMX PHLX and on NYSE Amex Options under the symbol “ALV”.

Some of the following discussions refer to non-U.S. GAAP financial measures: see reconciliations for “Organic sales”, “Trade working capital”, “Free cash flow”, “Net debt”, “Leverage ratio”, “Adjusted operating income”, “Adjusted operating margin” and “Adjusted earnings per share, diluted” provided below. Management believes that these non-U.S. GAAP financial measures provide supplemental information to investors regarding the performance of the Company’s business and assist investors in analyzing trends in the Company's business. Additional descriptions regarding management’s use of these financial measures are included below. Investors should consider these non-U.S. GAAP financial measures in addition to, rather than as substitutes for, financial reporting measures prepared in accordance with U.S. GAAP. These historical non-U.S. GAAP financial measures have been identified as applicable in each section of this report with a tabular presentation reconciling them to the most directly comparable U.S. GAAP financial measures. It should be noted that these measures, as defined, may not be comparable to similarly titled measures used by other companies.

~~During~~Our performance in the third quarter was very encouraging. Our organic sales growth continued to significantly outperform LVP and the adjusted operating income was a new third quarter record since the spin-off in 2018.

We are pleased that our strong performance in the third quarter was broad based, with improvements in several key areas - both year-over-year and sequentially - including gross and operating margin, labor efficiency and SG&A and RD&E costs in relation to sales. Cash flow was strong, and the debt leverage remained well within our target range while maintaining our dividend and almost tripling the number of shares repurchased compared to the second quarter.

We continue to work hard to secure a strong medium- and long-term competitive position. In the quarter, we took further steps towards our full year indications that support our medium term targets. First, we achieved new second quarter records for sales, adjusted operating income and operating cash flow since the Veoneer spin-off in 2018. Second, we achieved the price compensations from customers we planned for. Third, to secure our medium and long term competitiveness, we announced the accelerationdetailed a large part of our structural cost ~~reductions. Last week, we announced~~reduction intentions of reducing our indirect workforce by up to 2,000. In addition, the ~~first step towards the necessary optimization~~ongoing reorganization of our ~~cost structure to the market environment. This first step~~global functions and European operations is expected to ~~reduce costs~~lead to a reduced normalized tax rate. It is also encouraging for our medium- and long-term potential that we continue to improve our position in China with the fast-growing domestic OEMs. In the first nine months, we increased our sales to this group by ~~around $25 million in 2024, increasing to around $55 million in 2025 and to reach around $75 million when fully completed. Further actions will be announced as plans materialize.~~more than 50% year over year.

We ~~generated~~increase our full year sales indication to reflect that LVP has developed better than expected, even with the UAW strike in the U.S. We have continued to see an ~~organic growth~~improvement of ~~27%, growing 11pp faster~~supply chain stability throughout the year, with reduced customer call off volatility. However, the improvement is slower than ~~LVP due to successful product launches~~we had expected, as it deteriorated somewhat in Europe in the third quarter. This, together with the higher sales and ~~price compensation achievements. The strong volume growth combined with price compensations, cost saving activities and lower premium freight costs enabled us to improve~~adverse foreign currency exchange development, means that we expect a fourth quarter adjusted operating ~~income by 71%, despite substantial inflationary pressure and FX headwinds.~~

~~The Company is pleased that we delivered an adjusted RoCE~~margin (Non-U.S. GAAP measure) improvement year-over-year of more than 20%. We delivered strong operating and free cash flow in the quarter, driven by an improved adjusted operating income and reversal of the negative working capital effects from the first quarter,around 1.5-2pp, in line with ~~our previous indication. This contributed to an improved leverage ratio which supports our share repurchase ambitions.~~the previously communicated improvement pattern of around 2pp each quarter throughout 2023.

~~We saw continued improvement in call-off volatility~~Our performance in the ~~quarter but still higher volatility than pre-pandemic levels. We believe this reflects an improving global supply chain environment~~first nine months and the outlook for ~~both our customers and suppliers. Except for two isolated supply chain disruptions in Europe and Americas in~~ the final quarter ~~Autoliv's supply chain showed sequential improvement.~~

~~We reiterate our full year indications. Looking to the second half~~ of the year makes us confident that we expect the adjusted operating margin to be back-end loaded due to normal seasonality between the third and fourth quarters and the expected closing of price negotiations. The steps we took in the second quarter support our confidence in sequentially improving adjusted operating margin, which should allow us towill deliver a substantial full year increase in sales, operating cash flow and adjusted operating income. Together with the advancement of our structural cost reduction activities, the improving position with fast growing OEMs, the continued gradual improvement of supply chain stability, and the development of inflation compensation, we have a solid foundation for a continued strong development in the years to come, that support our medium-term targets.

Financial highlights in the three months period ended ~~June~~September 30, 2023

Change figures below compare to the same period of the previous year, except when stated otherwise.

~~27%~~11% organic sales ~~increase~~growth (Non-U.S. GAAP measure, see reconciliation table below)

~~8.0%~~9.4% adjusted operating margin (Non-U.S. GAAP measure, see reconciliation table below)

$~~1.93~~1.66 adjusted EPS (Non-U.S. GAAP measure, see reconciliation table below), ~~115%~~35% increase

Key business developments in the three months period ended ~~June~~September 30, 2023

Change figures below compare to the same period of the previous year, except when stated otherwise.

Global light vehicle production growth year-over-year was ~~15.5%~~3.8% (according to S&P Global ~~July~~October 2023) ~~mainly due to supply chain disruptions easing and the impact on Q2 2022 LVP from the Covid-19 shutdowns in China. Apart from several isolated supply chain disruptions in Europe and Americas~~ in the third quarter, wewith all major regions growing except China. We saw continued gradual improvement in call-off volatility as supply chains are less ~~strained.~~strained compared to a year earlier. However, volatility is still significantly higher than pre-pandemic levels, and low customer demand visibility and changes to customer call-offs with short notice still had a negative impact on our production efficiency and profitability in the quarter. We expect the current industry-wide supply chain disruptions to ~~gradually~~continue to fade in the ~~second half~~fourth quarter of 2023, but not enough to return to pre-pandemic levels of ~~efficiency.~~efficiency by year-end.

In Q2Q3 2023, cost pressures from labor, logistics, utilities, and other items had a negative impact on our profitability. Most of the inflationary cost pressure was offset by customer price and other compensations in the quarter. Raw material cost inflation and its impact on our profitability was ~~limited~~negligible in Q2Q3 2023. We expect the raw material price changes in 2023 ~~will~~to be largely be reflected in price changes in our products, albeit with delays of several months. We also expect continued cost pressure from broad based inflation relating to labor, logistics, utilities and other items, especially in Europe. We continue to execute on productivity and cost reduction activities to offset these cost pressures, and we continue to have challenging discussions with our customers on non-raw material cost inflation.

Autoliv expects its tax rate for full year 2023 to be lower than previously anticipated. The full year tax rate is now projected to be around 20% for full year 2023. This is due to the ongoing reorganization of our global functions and European operations, which is expected to lead to a reduced tax rate for 2023. These changes are also expected to reduce the normalized tax rate to be within a range of around 25-30% from 2024 onward.

The UAW strike has had negligible impact on our sales and profitability in the third quarter, with around $2 million in lost sales. We estimate that the current strike actions, as known as of October 19, 2023 by UAW are currently negatively impacting our weekly sales by around $6 million.

In June 2023, Autoliv communicated a cost reduction framework which included the intention of reducing our indirect headcount by up to 2,000. We announced more details on these initiatives on July 13, 2023 and followed up with another announcement with details on October 5, 2023. Based on the intended work force reductions in these announcements, we ~~executed settlement agreements, without admitting liability,~~estimate that ~~resolved~~ the ~~previously disclosed Andrews wrongful death product liability litigation~~annual cost reductions will amount to around $35 million in 2024, $65 million in 2025 and reaching $85 million when fully implemented. We expect to announce further details, as plans materialize further.

We expect 2024 to be an important step towards our medium-term target of 12% adjusted operating margin (Non-U.S. GAAP measure). We intend, as usual, to come back with all interested parties. The Company's out-of-pocket costs, including self-insurance retention costs and deductibles for the settlement, is $8 million. See below for the reconciliation of non-U.S. GAAP measures tables.a full year indication in connection with our fourth quarter earnings release in January next year.

The following table shows some of the key ratios management uses internally to analyze the Company's current and future financial performance and core operations as well as to identify trends in the Company’s financial conditions and results of operations. The Company has provided this information to investors to assist in meaningful comparisons of past and present operating results and to assist in highlighting the results of ongoing core operations. These ratios are more fully explained below and should be read in conjunction with the consolidated financial statements in the Company's Annual Report on Form 10-K and the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

The Company's management uses the Return on capital employed (ROCE) and Return on total equity (ROE) measures for purposes of comparing its financial performance with the financial performance of other companies in the industry and providing useful information regarding the factors and trends affecting the Company’s business. As used by the Company, ROCE is annualized operating income and income from equity method investments relative to average capital employed. The Company believes ROCE is a useful indicator of long-term performance both absolute and relative to the Company's peers as it allows for a comparison of the profitability of the Company’s capital employed in its business relative to that of its peers.

ROE is the ratio of annualized income (loss) relative to average total equity for the periods presented. The Company’s management believes that ROE is a useful indicator of how well management creates value for its shareholders through its operating activities and its capital management.

1) Outstanding receivables and outstanding inventory less outstanding payables. See calculation of this non-U.S. GAAP measure in the table below.

2) Outstanding receivables and outstanding inventory less outstanding payables relative to annualized quarterly sales.

9) Net debt adjusted for pension liabilities in relation to EBITDA. See tabular presentation reconciling this non-U.S. GAAP measure to U.S. GAAP below.

11) Operating income and income from equity method investments, relative to average capital employed.

three months period ended ~~June~~September 30, 2023 COMPARED WITH three months period ended ~~June~~September 30, 2022

Sales for all major product categories increased organically (Non-U.S. GAAP ~~measure, see reconciliation table above)~~measure) in the quarter. The largest contributor to the increase was ~~inflatable curtains and~~ steering wheels, followed by inflatable curtains, side airbags, and passenger airbags.

The main contributor to Seatbelt ~~products~~Products organic sales growth (Non-U.S. GAAP ~~measure, see reconciliation table above)~~measure) was Asia excl. China and Europe, followed by ~~China and~~ Americas.

Our global organic sales (Non-U.S. GAAP measure, see reconciliation table ~~above)~~below) increased by ~~27%~~11% compared to the global LVP increase of ~~15.5%~~3.8% (according to S&P Global, ~~July~~October 2023). The ~~11pp~~7pp outperformance was mainly driven by price increases and new product ~~launches and price increases.~~launches.

Autoliv organic sales growth outperformed LVP growth by ~~23pp in China, by 18pp~~15pp in Asia excl. China, by ~~7pp~~6pp in China, by 3pp in Americas and by ~~6pp~~2pp in Europe.

1) Non-U.S. GAAP measure, excluding effects from capacity ~~alignment,~~alignments, antitrust related matters and the Andrews litigation settlement.

Gross profit increased by ~~$121~~$82 million, and the gross margin increased by 1.3pp compared to the same quarter 2022. The gross profit increase was primarily driven by price increases, volume growth, ~~and~~ lower costs for material and premium freight. This was partly offset by increased costs for personnel related to volume growth and wage ~~inflation, as well as adverse effects from unfavorable exchange rates and energy costs.~~inflation.

S,G&Acosts increased by ~~$17~~$13 million compared to the prior year, mainly due to increased costs for personnel ~~and projects.~~as well as adverse foreign currency translation effects. S,G&A costs in relation to sales ~~decreased from 5.4% to 4.9%~~was unchanged at 4.6%.

R,D&E, net costs ~~increased by around $8 million~~was almost unchanged compared to the prior year, ~~mainly due to~~as higher costs for ~~personnel.~~personnel and adverse foreign currency translation effects were almost offset by higher engineering income. R,D&E, net, in relation to sales decreased from ~~5.4%~~4.6% to ~~4.6%~~4.1%.

Other income (expense), net was negative ~~$103~~$8 million compared to ~~$22~~negative $1 million in the ~~prior~~same period last year. The ~~prior year~~difference was ~~positively impacted by $21 million from a patent litigation settlement while Q2 2023 was negatively impacted by around $109 million~~mainly related to higher capacity alignment accruals in ~~accruals for capacity alignments~~the third quarter of 2023.

Operating income ~~decreased~~increased by ~~$30~~$61 million compared to the same period in 2022, mainly ~~as a consequence of accruals for capacity alignments and~~due to the increase in gross profit, partly offset by higher costs for S,G~~&A and R,D&E, net, partly offset by the higher gross profit.~~&A.

Adjusted operating income ~~(Non-U.S.~~(Non-U.S. GAAP measure, see reconciliation table below) increased by ~~$88~~$70 million compared to the prior year, mainly due to higher gross profit, partly offset by the higher costs for S,G~~&A and R,D&E, net.~~&A.

Financial and non-operating items, net,was negative ~~$11~~$30 million compared to negative $7$18 million a year ~~earlier,~~earlier. The difference was mainly due to increased interest expense as an effect of higher debt and higher interest ~~rates.~~rates and foreign currency revaluation effects.

Income before taxes ~~decreased~~increased by ~~$35~~$49 million compared to the prior year, mainly due to the ~~lower~~increase in operating ~~income.~~income, partly offset by a larger Financial and non-operating items, net.

Tax rate was ~~35.8%~~33.4% compared to ~~32.2%~~30.8% in the same period last year. Discrete tax items, net, ~~decreased~~increased the tax rate this quarter by ~~4.5pp.~~0.2pp. Discrete tax items increased the tax rate by ~~1.5pp~~1.4pp in the same period last year.

Earnings per share, diluted ~~decreased~~increased by ~~$0.29~~$0.36 compared to a year earlier. The main ~~driver~~drivers were ~~$1.32~~$0.49 from ~~capacity alignments and other adjustments,~~operating income partly offset by ~~$0.69~~$0.10 from ~~higher adjusted operating income (Non-U.S. GAAP measure, see reconciliation table below) and $0.35 from taxes.~~financial items.

~~SIX MONTHS PERIOD ENDED JUNE~~nine months period ended September 30, 2023 COMPARED WITH ~~SIX MONTHS PERIOD ENDED JUNE~~nine months period ended September 30, 2022

Sales for all major product categories increased organically (Non-U.S. GAAP ~~measure, see reconciliation table above)~~measure) in the ~~quarter.~~first nine months. The largest contributor to the increase was inflatable curtains and steering wheels, followed by side airbags and passenger airbags.

The main contributor to Seatbelt ~~products~~Products organic sales growth (Non-U.S. GAAP ~~measure, see reconciliation table above)~~measure) was Europe, followed by Americas, Asia excl. China, and China.

Our global organic sales (Non-U.S. GAAP measure, see reconciliation table ~~above)~~below) increased by ~~24%~~19% compared to the global LVP increase of ~~11.3%~~9.1% (according to S&P Global, ~~July~~October 2023). The ~~12pp~~10pp outperformance was mainly driven by new product launches and price increases.

Autoliv outperformed LVP by around ~~17pp in China, by~~ 15pp in Asia excl. China, by ~~9pp~~12pp in China, by 6pp in Europe and ~~by 7pp~~ in Americas.

1) Non-U.S. GAAP measure, excluding effects from capacity ~~alignment,~~alignments, antitrust related matters, the Andrews litigation settlement, and gain on sale of property in the first quarter of 2022.

Gross profit increased by ~~$212~~$294 million, and the gross margin increased by ~~1.5pp~~1.4pp compared to the same period in 2022. The gross profit increase was primarily driven by price increases, volume growth and lower costs for premium freight. This was partly offset by increased costs for personnel related to higher volumes and wage inflation as well as adverse effects from ~~higher costs for raw materials, unfavorable FX effects~~foreign currency translation and higher costs for energy.

S,G&Acosts increased by ~~$33~~$46 million compared to the prior year, mainly due to increased costs for personnel ~~and projects, partly offset by positive currency translation effects.~~projects. S,G&A costs in relation to sales decreased from ~~5.4%~~5.1% to ~~5.1%~~4.9%.

R,D&E, net costs increased by around ~~$18~~$19 million compared to the prior year, mainly due to higher costs for ~~personnel, partly offset by positive currency translation effects.~~personnel. R,D&E, net, in relation to sales decreased from ~~5.2%~~5.0% to ~~4.6%~~4.4%.

Other income (expense), net was negative ~~$107~~$115 million compared to ~~$92~~positive $91 million in the prior year. The prior year was positively impacted by around an $80 million gain from the sale of a property in Japan and around $20 million from a patent litigation settlement, partly offset by around $10 million in capacity alignment ~~provision~~provisions for the closure of a plant in South Korea while the first ~~half~~nine months of 2023 was negatively impacted by around ~~$112~~$105 million in accruals for capacity alignments.

Operating income ~~decreased~~increased by ~~$37~~$24 million compared to the same period in 2022, mainly ~~as a consequence of~~due to higher gross profit, partly offset by the changes in Other income (expense), net and the higher costs for S,G&A and R,D&E, ~~net, partly offset by the higher gross profit.~~net.

Adjusted operating income (Non-U.S. GAAP measure, see reconciliation table below) increased by ~~$151~~$221 million compared to the prior year, mainly due to higher gross profit, partly offset by the higher costs for S,G&A and R,D&E, net.

Financial and non-operating items, net, was negative ~~$29~~$60 million compared to negative ~~$22~~$40 million a year earlier, mainly due to increased interest expense as an effect of higher debt and higher interest rates.

Income before taxes ~~decreased~~increased by ~~$45~~$3 million compared to the prior year, mainly due to the ~~lower~~higher operating income ~~and~~partly offset by the increased interest expense.

Tax rate was 33.4% compared to ~~31.3%~~31.1% in the same period last year. Discrete tax items, net, decreased the tax rate in this year by ~~1.5pp.~~0.6pp. Discrete tax items increased the tax rate by ~~1.0pp~~1.2pp in the same period last year.

Earnings per share, diluted decreased by ~~$0.38~~$0.02 compared to a year earlier. The main drivers behind the decrease were ~~$1.83~~$0.17 from ~~capacity alignments~~financial items and ~~other adjustments,~~$0.14 from lower operating income, partly offset by ~~$1.20~~$0.23 from ~~higher adjusted operating income (Non-U.S. GAAP measure, see reconciliation table below) and $0.29 from~~ taxes.

The Company does not have any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on its financial position, results of operations or cash flows. The Company’s future contractual obligations have not changed materially from the amounts reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 16, 2023.

Trade working capital (Non-U.S. GAAP measure, see calculation table below) decreased by ~~$87~~$11 million compared to the same period last year, where the main drivers were ~~$541~~$354 million in higher accounts payable partly offset by ~~$410~~$286 million in higher receivables and ~~$44~~$58 million in higher inventories. Compared to Q1the second quarter of 2023, trade working capital ~~was reduced~~increased by ~~$117~~$11 million, driven by ~~$161~~$35 million in higher inventories, partly offset by $14 million in higher accounts payable and ~~$39~~$10 million in lower ~~inventories partly offset by $83 million in higher~~ receivables.

Operating cash flow ~~improved~~decreased by ~~$430~~$30 million to ~~$379~~$202 million compared to the same period last year, mainly due to ~~improved adjusted operating income and a reversal of the negative~~less favorable working capital effects ~~from the first quarter 2023.~~partly offset by higher net income.

Capital expenditure, net decreased by ~~$14~~$12 million compared to the same period the previous year. Capital expenditure, net in relation to sales was ~~4.7%~~5.8% vs. ~~6.7%~~7.1% a year earlier.

Free cash flow (Non-U.S. GAAP measure, see calculation table below) was ~~$255~~$50 million compared to ~~negative $190~~$68 million in the same period prior year. The ~~improvement~~decrease was mainly due to the ~~higher~~lower operating cash flow ~~and~~partly offset by lower capital expenditure, net.

Cash conversion (Non-U.S. GAAP measure) defined as free cash flow (Non-U.S. GAAP measure, see calculation table below) in relation to net income,was ~~481%~~37% in the ~~period, positively impacted by significant capacity alignment accruals in the quarter.~~period.

Net debt (Non-U.S. GAAP measure, see reconciliation table below) was ~~$1,299~~$1,375 million as of ~~June~~September 30, 2023, which was ~~$19~~$87 million ~~lower~~higher than a year earlier.

Liquidity position. As of ~~June~~September 30, 2023, our cash balance was around $0.5 billion, and including committed, unused loan facilities, our liquidity position was around $1.6 billion.

Leverage ratio (Non-U.S. GAAP measure, see calculation table below). As of ~~June~~September 30, 2023, the Company had a leverage ratio of 1.3x compared to ~~1.7x~~1.6x as of ~~June~~September 30, 2022, as ~~the net debt (Non-U.S. GAAP measure, see reconciliation table below) decreased and~~ the 12 months trailing adjusted EBITDA (Non-U.S. GAAP ~~measure, see reconciliation table below)~~measure) increased more than the net debt (Non-U.S. GAAP measure) increased.

Total equity decreased by $1$5 million compared to ~~June~~September 30, 2022. This was mainly due to $226 million in dividend payment and stock repurchases of ~~$157~~$257 million ~~as well as $30 million in adverse currency translation effects,~~ partly offset by ~~$390~~$418 million from net ~~income.~~income and $36 million in positive currency translation effects.

Operating cash flow ~~increased~~increased by ~~$315~~$285 million compared to the same period last year to ~~$334~~$535 million, mainly due to higher adjusted operating income and ~~positive~~less negative working capital effects.

Capital expenditure, net increased by ~~$112~~$99 million, mainly due to the impact on the prior year of $95 million from the sale of property, plant and equipment. Capital expenditure, net in relation to sales was ~~5.2%~~5.4% vs. ~~3.7% a~~4.9% the prior year ~~earlier.~~period.

Free cash flow (Non-U.S. GAAP measure, see reconciliation table below) was ~~$66~~$117 million, compared to negative ~~$137~~$69 million in the same period ~~prior~~last year. The improvement was due to the higher operating cash flow partly offset by higher capital expenditure, net.

Cash conversion (Non-U.S. GAAP measure, see reconciliation table below) defined as free cash flow (Non-U.S. GAAP measure, see reconciliation table below) in relation to net income,was ~~52%~~45% in the period.

The Company believes that comparability between periods is improved through the exclusion of certain items. To assist investors in understanding the operating performance of Autoliv's business, it is useful to consider certain U.S. GAAP measures exclusive of these items.

With respect to the Andrews litigation settlement, the Company has treated this specific settlement as a non-recurring charge because of the unique nature of the lawsuit, including the facts and legal issues involved.

Accordingly, the tables below reconcile from U.S. GAAP to the equivalent non-U.S. GAAP measure.

Reconciliation of U.S. GAAP financial measures to “Adjusted operating income”, “Adjusted operating margin” and “Adjusted Earnings per share, diluted”

1) Effects from capacity ~~alignment,~~alignments, antitrust related matters and the Andrews litigation settlement.

1) Effects from capacity alignments, antitrust related matters and the Andrews litigation settlement, including gain on sale of property in the first quarter of 2022.

1) The tax is calculated based on the tax laws in the respective jurisdiction(s) of the adjustment(s).

2) The tax is calculated based on the tax laws in the respective jurisdiction(s) of the adjustment(s).

The Company uses the non-U.S. GAAP measure “Trade working capital,” as defined in the table below, in its communications with investors and for management’s review of the development of the trade working capital cash generation from operations. The reconciling items used to derive this measure are, by contrast, managed as part of the Company’s overall cash and debt management, but they are not part of the responsibilities of day-to-day operations’ management.

Management uses the non-U.S GAAP measure "Net debt" to analyze the amount of debt the Company can incur under its debt policy. Management believes that this policy also provides guidance to credit and equity investors regarding the extent to which the Company would be prepared to leverage its operations. The Company, from time to time enters into “debt-related derivatives” (DRDs) as a part of its debt management and as part of efficiently managing the Company’s overall cost of funds. Creditors and credit rating agencies use net debt adjusted for DRDs in their analyses of the Company’s debt, therefore the Company provides this non-U.S. GAAP measure. DRDs are fair value adjustments to the carrying value of the underlying debt. Also included in the DRDs is the unamortized fair value adjustment related to a discontinued fair value hedge that will be amortized over the remaining life of the debt. By adjusting for DRDs, the total financial liability of net debt is disclosed without grossing debt up with currency or interest fair values.

The non-U.S. GAAP measure “Net debt” is also used in the non-U.S. GAAP measure “Leverage ratio”. Management uses the non-U.S. GAAP measure “Leverage Ratio” to analyze the amount of debt the Company can incur under its debt policy. Management believes that this policy also provides guidance to credit and equity investors regarding the extent to which the Company would be prepared to leverage its operations. The Company's long-term target for the leverage ratio (sum of net debt plus pension liabilities divided by EBITDA) is 1.0x with the aim to operate within the range of 0.5x to 1.5x. For details and calculation of leverage ratio, refer to the table below.

1) Net debt (non-U.S. GAAP measure) is short- and long-term debt and debt-related derivatives, less cash and cash equivalents.

3) Interest expense, net including cost for extinguishment of debt, if any, less interest income.

Management uses the non-U.S. GAAP measure ~~free~~“free cash ~~flow~~flow” to analyze the amount of cash flow being generated by the Company’s operations after capital expenditure, net. This measure indicates the Company’s cash flow generation level that enables strategic value creation options such as dividends or acquisitions. For details on the calculation of free cash flow, see the table below. Management uses the non-U.S. GAAP measure “cash conversion” to analyze the proportion of net income that is converted into free cash flow. The measure is a tool to evaluate how efficiently the Company utilizes its resources. For details on cash conversion, see the table below.

At ~~June~~September 30, 2023, total headcount increased by ~~6,500~~3,400 compared to a year earlier. The indirect workforce ~~increased~~decreased by 2%1% while the direct workforce increased by ~~13%~~7%, reflecting that sales grew organically by ~~27%~~11% in the ~~second~~third quarter compared to a year earlier.

Compared to ~~March 31,~~June 30, 2023, total headcount was ~~virtually unchanged. Our~~unchanged, with a 1% increase in direct headcount ~~reductions announced on July 13, 2023 is not yet reflected~~and 2% decrease in ~~the totals.~~indirect headcount.

~~The Company's~~Our outlook indications for 2023 are mainly based on ~~its~~our customer call-offs, a full year 2023 global LVP growth of around 4%7%, ~~that the Company achieves its~~achievement of our targeted cost compensation effects, and ~~that~~a reduction of customer call-off ~~volatility~~volatility. Our full year 2023 indications are also based on the assumption that the UAW strike is ~~reduced.~~not prolonged beyond what is included in the S&P Global October outlook.

The forward-looking non-U.S. GAAP financial measures above are provided on a non-U.S. GAAP basis. The Company has not provided a U.S. GAAP reconciliation of these measures because items that impact these measures, such as costs and gains related to capacity alignments and antitrust matters, cannot be reasonably predicted or determined. As a result, such reconciliation is not available without unreasonable efforts and the Company is unable to determine the probable significance of the unavailable information.

As of ~~June~~September 30, 2023, there have been no material changes to the information related to quantitative and qualitative disclosures about market risk that were provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 16, 2023.

An evaluation has been carried out, under the supervision and with the participation of the Company's management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on such evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company's disclosure controls and procedures are effective.

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

In the ordinary course of our business, we are subject to legal proceedings brought by or against us and our subsidiaries.

See Part I, Item 1, "Financial Statements, Note 9 Contingent Liabilities" of this Quarterly Report on Form 10-Q for a summary of certain ongoing legal proceedings. Such information is incorporated into this Part II, Item 1—"Legal Proceedings" by reference.

As of ~~June~~September 30, 2023, there have been no material changes to the risk factors that were previously disclosed in Item 1A in the Company’s Form 10-K for the year ended December 31, 2022 filed with the SEC on February 16, 2023.

The following table provides information with respect to common stock repurchases by the Company during the three months period ended ~~June~~September 30, 2023.

(1) The repurchases are being executed from time to time, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. For accounting purposes, shares repurchased under our stock repurchase programs are recorded based upon the settlement date of the applicable trade.

(2) Average price paid per share includes costs associated with the repurchases.

(3) On November 16, 2021, the Company announced that its Board of Directors approved a new stock repurchase program that authorizes the Company to repurchase up to $1.5 billion or up to 17 million common shares, whichever comes first, between January 2022 and the end of 2024.

During the three months period ended ~~June~~September 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Delaware		51-0378542
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

Klarabergsviadukten 70, Section B7
Box 70381,
Stockholm, Sweden		SE-107 24
(Address of principal executive offices)		(Zip Code)


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock (par value $1.00 per share)	ALV	New York Stock Exchange


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐


Net Sales by Products	Three Months Ended June 30,				Six Months Ended June 30,				Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022		2023		2022		2023		2022
Airbags, Steering Wheels and Other1)	$	1,757	$	1,336	$	3,430	$	2,716	$	1,761	$	1,510	$	5,191	$	4,226
Seatbelt Products1)		878		746		1,698		1,489
Seatbelt Products and Other1)										835		792		2,533		2,281
Total net sales	$	2,635	$	2,081	$	5,127	$	4,206	$	2,596	$	2,302	$	7,724	$	6,507

Net Sales by Region	Three Months Ended June 30,				Six Months Ended June 30,				Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022		2023		2022		2023		2022
China	$	497	$	363	$	950	$	810	$	538	$	537	$	1,488	$	1,347
Asia, excl. China		471		369		954		779		495		418		1,449		1,197
Americas		916		738		1,747		1,431		918		794		2,665		2,225
Europe		751		611		1,476		1,186		646		552		2,122		1,738
Total net sales	$	2,635	$	2,081	$	5,127	$	4,206	$	2,596	$	2,302	$	7,724	$	6,507


	Three Months Ended						Six Months Ended						Three Months Ended						Nine Months Ended
	or As of June 30,						or As of June 30,						or As of September 30,						or As of September 30,
	2023			2022			2023			2022			2023			2022			2023			2022
Trade working capital1)		1,292			1,379			1,292			1,379			1,303			1,314			1,303			1,314
Trade working capital relative to sales, %2)		12.3	%		16.6	%		12.3	%		16.6	%		12.5	%		14.3	%		12.5	%		14.3	%
Receivables outstanding relative to sales, %3)		20.8	%		21.4	%		20.8	%		21.4	%		21.0	%		20.6	%		21.0	%		20.6	%
Inventory outstanding relative to sales, %4)		9.0	%		10.8	%		9.0	%		10.8	%		9.5	%		10.0	%		9.5	%		10.0	%
Payables outstanding relative to sales, %5)		17.5	%		15.7	%		17.5	%		15.7	%		17.9	%		16.3	%		17.9	%		16.3	%

Gross margin, %6)		17.0	%		15.7	%		16.1	%		14.6	%		17.9	%		16.7	%		16.7	%		15.3	%
Operating margin, %7)		3.6	%		6.0	%		4.3	%		6.1	%		8.9	%		7.4	%		5.9	%		6.6	%

Capital employed8)		3,856			3,876			3,856			3,876			3,861			3,779			3,861			3,779
Net debt9)		1,299			1,318			1,299			1,318			1,375			1,288			1,375			1,288
Return on total equity, %10)		8.2	%		12.1	%		9.8	%		12.4	%		21.3	%		16.8	%		13.5	%		13.8	%
Return on capital employed, %11)		9.5	%		13.1	%		11.4	%		13.8	%		24.2	%		18.0	%		15.6	%		15.3	%

Headcount at period-end12)		71,200			64,700			71,200			64,700			71,200			67,800			71,200			67,800


☒	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


	Three Months Ended June 30,							Components of change in net sales						Three Months Ended September 30,							Components of change in net sales
	2023		2022		Reported change			Currency effects 1)			Organic 3)			2023		2022		Reported change			Currency effects 1)			Organic 3)
Airbags, Steering Wheels and Other2)	$	1,757	$	1,336		32	%		(0.2	)%		32	%	$	1,761	$	1,510		17	%		1.9	%		15	%
Seatbelt products 2)		878		746		18	%		0.5	%		17	%
Seatbelt products and Other2)															835		792		5.5	%		2.9	%		2.6	%
Total	$	2,635	$	2,081		27	%		0.0	%		27	%	$	2,596	$	2,302		13	%		2.2	%		11	%

Asia	$	968	$	732		32	%		(5.0	)%		37	%	$	1,033	$	955		8.1	%		(3.7	)%		12	%
Whereof: China		497		363		37	%		(5.7	)%		43	%		538		537		0.1	%		(5.4	)%		5.6	%
Asia excl. China		471		369		28	%		(4.3	)%		32	%		495		418		18	%		(1.5	)%		20	%
Americas		916		738		24	%		3.1	%		21	%		918		794		16	%		5.0	%		11	%
Europe		751		611		23	%		2.3	%		21	%		646		552		17	%		8.4	%		8.5	%
Total	$	2,635	$	2,081		27	%		0.0	%		27	%	$	2,596	$	2,302		13	%		2.2	%		11	%


	Three Months Ended June 30, 2023									Three Months Ended June 30, 2022									Three Months Ended September 30, 2023									Three Months Ended September 30, 2022
	Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP			Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP			Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP			Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP
Operating income	$	94		$	118		$	212		$	124		$	0		$	124		$	232		$	11		$	243		$	171		$	2		$	173
Operating margin, %		3.6	%		4.5	%		8.0	%		6.0	%		0.0	%		6.0	%		8.9	%		0.4	%		9.4	%		7.4	%		0.1	%		7.5	%
Earnings per share, diluted	$	0.61		$	1.31		$	1.93		$	0.91		$	(0.00	)	$	0.90		$	1.57		$	0.09		$	1.66		$	1.21		$	0.02		$	1.23


	Six Months Ended June 30, 2023									Six Months Ended June 30, 2022									Nine Months Ended September 30, 2023									Nine Months Ended September 30, 2022
	Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP			Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP			Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP			Reported U.S. GAAP			Adjustments1)			Non-U.S. GAAP
Operating income	$	221		$	122		$	343		$	258		$	(66	)	$	192		$	453		$	133		$	586		$	429		$	(64	)	$	365
Operating margin, %		4.3	%		2.4	%		6.7	%		6.1	%		(1.6	)%		4.6	%		5.9	%		1.7	%		7.6	%		6.6	%		(1.0	)%		5.6	%
Earnings per share, diluted	$	1.47		$	1.35		$	2.82		$	1.85		$	(0.49	)	$	1.36		$	3.04		$	1.44		$	4.48		$	3.06		$	(0.47	)	$	2.58


	June 30, 2023			March 31, 2023			June 30, 2022			September 30, 2023			June 30, 2023			September 30, 2022
Receivables, net	$	2,189		$	2,106		$	1,779		$	2,179		$	2,189		$	1,893
Inventories, net		947			986			903			982			947			924
Accounts payable		(1,844	)		(1,683	)		(1,303	)		(1,858	)		(1,844	)		(1,503	)
Trade working capital	$	1,292		$	1,409		$	1,379		$	1,303		$	1,292		$	1,314


Financial measure		Full year indication
Organic sales growth		Around ~~15%~~17%
Foreign currency impact on net sales		Around 1% positive
Adjusted operating margin 1)		Around 8.5%-9%
Tax rate 2)		Around ~~32%~~20%
Operating cash flow 3)		Around $900 million
Capital expenditures, net % of sales		Around 6%
1) Excluding effects from capacity alignments, antitrust related matters, the Andrews litigation settlement and other discrete items.
2) Excluding unusual tax items.
3) Excluding unusual items.


	New York Stock Exchange (NYSE)
Period	Total Number of Shares Purchased (1)		Average Price Paid per Share (USD) (2)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)		Maximum Number of Shares that Yet May Be Purchased Under the Plans or Programs (3)
April 1-30, 2023		17,400	$	86.22		1,908,131		15,091,869
May 1-31, 2023		388,275	$	85.00		2,296,406		14,703,594
June 1-30, 2023		69,617	$	86.20		2,366,023		14,633,977


Exhibit No.		Description

3.1		Autoliv’s Restated Certificate of Incorporation, as amended, incorporated herein by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 22, 2015).

3.2		Autoliv’s Third Restated By-Laws, incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K (File No. 001-12933, filing date December 18, 2015).

4.1		Indenture, dated March 30, 2009, between Autoliv, Inc. and U.S. Bank National Association, as trustee, incorporated herein by reference to Exhibit 4.1 to Autoliv’s Registration Statement on Form 8-A (File No. 001-12933, filing date March 30, 2009).

4.2		Second Supplemental Indenture (including Form of Global Note), dated March 15, 2012, between Autoliv, Inc. and U.S. Bank National Association, as trustee, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 001-12933, filing date March 15, 2012).

4.3		Form of Note Purchase and Guaranty Agreement dated April 23, 2014, among Autoliv ASP, Inc., Autoliv, Inc. and the purchasers named therein, incorporated herein by reference to Exhibit 4.6 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 25, 2014).

4.4		Amendment and Waiver 2014 Note Purchase and Guaranty Agreement, dated May 24, 2018, among Autoliv, Inc., Autoliv ASP, Inc. and the noteholders named therein, incorporated herein by reference to Exhibit 4.4 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date July 27, 2018).

4.5		General Terms and Conditions for Swedish Depository Receipts in Autoliv, Inc. representing common shares in Autoliv, Inc., effective as of May 30, 2018, with Skandinaviska Enskilda Banken AB (publ) serving as a custodian, incorporated herein by reference to Exhibit 4.5 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date July 27, 2018).

4.6		Agency Agreement dated June 26, 2018 among Autoliv, Inc., Autoliv ASP, Inc. and HSBC Bank PLC, incorporated herein by reference to Exhibit 4.6 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date July 27, 2018).

4.7		Amended and Restated Agency Agreement, dated February 22, 2022, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein, incorporated herein by reference to Exhibit 4.14 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 22, 2022).

4.8		Base Listing Particulars Agreement, dated February 17, 2023, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 001-12933, filing date March 16, 2023).

4.9		Amended and Restated Programme Agreement, dated February 17, 2023, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein, incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K (File No. 001-12933, filing date March 16, 2023).

~~10.1*+~~		~~Employment Agreement, dated May 17, 2023, by and between Autoliv, Inc. and Petra Albuschus.~~

~~10.2+~~10.1+		Amendment No. 1 ~~dated June 1, 2023,~~ to ~~the~~ Employment Agreement, dated ~~February 15, 2019, by and between Autoliv, Inc. and Magnus Jarlegren.~~

~~10.3*+~~		~~Mutual Separation Agreement, dated July 10,~~October 1, 2023, by and between Autoliv, Inc. and ~~Frithjof Oldorff.~~Colin Naughton.

~~10.4*+~~		~~Autoliv, Inc. Non-Employee Director Compensation Policy effective May 1, 2023.~~

~~10.5*+~~		~~Form of Non-Employee Director Restricted Stock Units Grant Agreement (2023) to be used under the Autoliv, Inc. 1997 Stock Incentive Plan, as amended and restated.~~

31.1*		Certification of the Chief Executive Officer of Autoliv, Inc. pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.

31.2*		Certification of the Chief Financial Officer of Autoliv, Inc. pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.

32.1*		Certification of the Chief Executive Officer of Autoliv, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of the Chief Financial Officer of Autoliv, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


101.INS*		Inline XBRL Instance Document – The instance document does not appear in the Interactive Date File because its XBRL tags are embedded within the inline XBRL document.

101.SCH*		Inline XBRL Taxonomy Extension Schema Document.

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document.


101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104*		Cover Page Interactive Data File (embedded within the inline XBRL document).


By:		/s/ Fredrik Westin
		Fredrik Westin
		Chief Financial Officer
		(Duly Authorized Officer and Principal Financial Officer)